Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00756899 · ClinicalTrials.gov registry record

Vitamin D Deficiency and Low Bone Mineral Content in Children

A clinical trial of Obesity and Vitamin D Deficiency, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
45
Enrollment target
1
Study location

NCT00756899: Completed study of Obesity and Vitamin D Deficiency, sponsored by University of Massachusetts, Worcester.

NCT00756899 is a study of Obesity and Vitamin D Deficiency that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 45 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00756899, a study of Obesity and Vitamin D Deficiency, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

The Vitamin D study is designed to investigate the effect of body fat mass on vitamin D levels in children. Earlier studies have shown that individuals with increased fat mass may have low vitamin D levels. Our specific hypothesis states that children with increased fat mass will have lower blood levels of vitamin D when compared to non-obese children.Since vitamin D is the primary hormone for bone mineralization in humans, low levels of vitamin D could lead to decreased bone mineral content in these children.

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2008-07
Est. Completion 2012-05

What the finished NCT00756899 record still lists

NCT00756899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT00756899 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00756899 about?

NCT00756899 is a clinical study titled "Vitamin D Deficiency and Low Bone Mineral Content in Children". The Vitamin D study is designed to investigate the effect of body fat mass on vitamin D levels in children. Earlier studies have shown that individuals with increased fat mass may have low vitamin D levels. Our specific hypothesis states that children with increased fat mass will have lower blood l...

What is the current status of trial NCT00756899?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-07. Estimated completion is 2012-05.

What conditions does trial NCT00756899 study?

This clinical trial studies the following conditions: Obesity, Vitamin D Deficiency.

Who is sponsoring clinical trial NCT00756899?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00756899 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00756899's enrollment target sits among peer trials

45 752nd of 1053 higher than 295 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00756899, the US trial registry maintained by the National Library of Medicine. NCT00756899 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.